Examination of Several Potential Mechanisms for the Negative Outcome in a Clinical Stroke Trial of Enlimomab, a Murine Anti-Human Intercellular Adhesion Molecule-1 Antibody: A Bedside-to-Bench Study

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Stroke

• Publication date

  2001-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HS3211.098535PMID 11692032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of the role of intercellular adhesion molecule 1 in a rodent model of chronic venous hypertension.

  2000cited by this paper
• Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood.

  1999cited by this paper
• Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation.

  1999cited by this paper
• ICAM-1 affects reperfusion injury and graft function after cardiac transplantation.

  1999cited by this paper
• Safety, Pharmacokinetics and Biological Activity of Enlimomab (Anti-ICAM-1 Antibody): An Open-Label, Dose Escalation Study in Patients Hospitalized for Acute Stroke

  1998cited by this paper
• A monoclonal antibody against ICAM-1 suppresses hepatic ischemia-reperfusion injury in rats.

  1997cited by this paper
• Role of polymorphic Fc receptor Fc gammaRIIa in cytokine release and adverse effects of murine IgG1 anti-CD3/T cell receptor antibody (WT31).

  1997cited by this paper
• ICAM‐1 mediates leukocyte‐endothelium adhesive interactions in the reversed passive Arthus reaction

  1996cited by this paper
• Anti‐adhesion molecule and nitric oxide protection strategies in ischemic stroke

  1996cited by this paper
• Experimental Antileukocyte Interventions in Cerebral Ischemia

  1996cited by this paper
• Treatment of focal cerebral ischemia with synthetic oligopeptide corresponding to lectin domain of selectin.

  1996cited by this paper
• Inflammatory reactions at the blood-endothelial interface in acute stroke.

  1996cited by this paper
• Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction.

  1995cited by this paper
• Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat.

  1995cited by this paper
• Intercellular adhesion molecule 1 (ICAM‐1) expression and its role in neutrophil‐induced ischemia‐reperfusion injury in rat liver

  1995cited by this paper
• Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat).

  1994cited by this paper
• P‐Selectin and Intercellular Adhesion Molecule‐1 Expression After Focal Brain Ischemia and Reperfusion

  1994cited by this paper
• Complement and tumor necrosis factor‐α contribute to Mac‐1 (CD11b/CD18) up‐regulation and systemic neutrophil activation during endotoxemia in vivo

  1994cited by this paper
• Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat.

  1994cited by this paper
• Anti‐ICAM‐1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat

  1994cited by this paper
• Postischemic Administration of an Anti‐Mac‐1 Antibody Reduces Ischemic Cell Damage After Transient Middle Cerebral Artery Occlusion in Rats

  1994cited by this paper
• Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?

  1994cited by this paper
• Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model.

  1993cited by this paper
• Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression.

  1993cited by this paper
• Selectins.

  1993cited by this paper
• Monocyte adherence to human vascular endothelium.

  1993cited by this paper
• Monocyte adherence to human vascular endothelium

  1993cited by this paper
• BW619C89, a Glutamate Release Inhibitor, Protects Against Focal Cerebral Ischemic Damage

  1993cited by this paper
• Endothelial-leukocyte adhesion molecules.

  1993cited by this paper
• Effect of Brain Edema on Infarct Volume in a Focal Cerebral Ischemia Model in Rats

  1993cited by this paper
• Novel antibody drug products.

  1992cited by this paper
• Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxidase activity assay and histologic verification

  1991cited by this paper
• Polymorphonuclear Leukocytes Occlude Capillaries Following Middle Cerebral Artery Occlusion and Reperfusion in Baboons

  1991cited by this paper
• In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.

  1990cited by this paper
• An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4).

  1990cited by this paper
• Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells.

  1990cited by this paper
• Lectin binding by resting and reactive microglia

  1987cited by this paper
• Immunosuppression with monoclonal anti-T3 antibody (WT32) in renal transplantation.

  1987cited by this paper
• Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period.

  1986cited by this paper
• Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.

  1985cited by this paper
• Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.

  1985cited by this paper
• Human immune response to multiple injections of murine monoclonal IgG.

  1985cited by this paper
• The rat brain in stereotaxic coordinates: Authors: George Paxinos & Charles Watson Academic Press Australia, 1982 Softback, 154 pages (including 71 plates), 35.00 Aust $

  1983cited by this paper

• Consensus Review of Perioperative Immune Modulation for Endovascular Thrombectomy Following Ischemic Stroke.

  2026cites this paper
• CD4+ T cells in ischemic stroke: effects and therapeutic targets

  2025cites this paper
• Neutrophils in Intracerebral Hemorrhage: Roles, Mechanisms, and Therapeutic Implications

  2025cites this paper
• From first responders to outcome modulators: The evolving paradigm of neutrophils in ischemic stroke and thrombolysis.

  2025cites this paper
• Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model

  2024cites this paper
• Intersecting Pathways: The Role of Metabolic Dysregulation, Gastrointestinal Microbiome, and Inflammation in Acute Ischemic Stroke Pathogenesis and Outcomes

  2024cites this paper
• The NLRP3 inflammasome in ischemic stroke

  2024cites this paper
• Anti-Atherosclerotic Properties of Aronia melanocarpa Extracts Influenced by Their Chemical Composition Associated with the Ripening Stage of the Berries

  2024cites this paper
• Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies

  2023cites this paper
• Thromboinflammatory challenges in stroke pathophysiology

  2023cites this paper
• Extracellular vesicles set the stage for brain plasticity and recovery by multimodal signalling

  2023cites this paper
• ICAM-1 on the luminal surface of endothelial cells is induced to a greater extent in mouse retina than in other tissues in diabetes

  2022cites this paper
• Sirtuin-1 - Mediated NF-κB Pathway Modulation to Mitigate Inflammasome Signaling and Cellular Apoptosis is One of the Neuroprotective Effects of Intra-arterial Mesenchymal Stem Cell Therapy Following Ischemic Stroke

  2022cites this paper
• Neuroprotection Following Stroke

  2021cites this paper
• Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier

  2021cites this paper
• Downregulation of CD151 restricts VCAM-1 mediated leukocyte infiltration to reduce neurobiological injuries after experimental stroke

  2021cites this paper
• Stroke and immunotherapy: Potential mechanisms and its implications as immune‐therapeutics

  2021cites this paper
• Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review

  2020cites this paper
• Natalizumab in acute ischemic stroke (ACTION II)

  2020cites this paper
• Stroke and the immune system: A review of the new strategies.

  2020cites this paper
• Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy

  2020cites this paper
• TNFα and microRNA-15b expression changes in experimental model of subarachnoid haemorrhage

  2019cites this paper
• The Hazard of Negative (Not Neutral) Trials on Treatment of Acute Stroke: A Review.

  2019cites this paper
• N2 neutrophils may participate in spontaneous recovery after transient cerebral ischemia by inhibiting ischemic neuron injury in rats.

  2019cites this paper
• Lung‐Derived SOD3 Attenuates Neurovascular Injury After Transient Global Cerebral Ischemia

  2019cites this paper
• The Inflammatory Response After Ischemic Stroke: Targeting β2 and β1 Integrins

  2019cites this paper
• Thymosin β4 for the treatment of acute stroke: neurorestorative or neuroprotective?

  2018cites this paper
• Attenuation of Experimental Autoimmune Encephalomyelitis in a Common Marmoset Model by Dendritic Cell-Modulating Anti-ICAM-1 Antibody, MD-3

  2018cites this paper
• Ultrasound-Enhanced Protective Effect of Tetramethylpyrazine via the ROS/HIF-1A Signaling Pathway in an in Vitro Cerebral Ischemia/Reperfusion Injury Model.

  2018cites this paper
• Deletion of the ageing gene p 66 Shc reduces early stroke size following ischaemia / reperfusion brain injury

  2018cites this paper
• Ginkgo biloba Extract Inhibits Astrocytic Lipocalin-2 Expression and Alleviates Neuroinflammatory Injury via the JAK2/STAT3 Pathway After Ischemic Brain Stroke

  2018cites this paper
• The Role of Inflammatory Response in Stroke Associated Programmed Cell Death

  2018cites this paper
• Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management

  2018cites this paper
• History of Neuroprotection: Trials and Tribulations

  2017cites this paper
• Cholinergic Anti-inflammatory Pathway and Stroke.

  2017cites this paper
• Neuroinflammatory biomarkers: From stroke diagnosis and prognosis to therapy.

  2016cites this paper
• KDM7A histone demethylase mediates TNF-α-induced ICAM1 protein upregulation by modulating lysosomal activity.

  2016cites this paper
• 10 – Inflammation and Immune Response

  2016cites this paper
• Adhesion Molecules: Master Controllers of the Circulatory System.

  2016cites this paper
• Roles of Neutrophils in Stroke

  2016cites this paper
• Natalizumab: a new therapy for acute ischemic stroke?

  2016cites this paper
• Phytochemicals in Ischemic Stroke

  2016cites this paper
• 55 – Pharmacologic Modification of Acute Cerebral Ischemia

  2016cites this paper
• Clinical Trials of Immunomodulation in Ischemic Stroke

  2016cites this paper
• Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.

  2016cites this paper
• Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage

  2015cites this paper
• Targeting Neutrophils in Ischemic Stroke: Translational Insights from Experimental Studies

  2015cites this paper
• Neuroprotective activity of (1S,2E,4R,6R,-7E,11E)-2,7,11-cembratriene-4,6-diol (4R) in vitro and in vivo in rodent models of brain ischemia.

  2015cites this paper
• The Ischemic Penumbra and Cell Survival

  2015cites this paper
• The impact of selectins on mortality in stable carotid atherosclerosis

  2015cites this paper
• Immune interventions in stroke

  2015cites this paper
• Blocking of &agr;4 Integrin Does Not Protect From Acute Ischemic Stroke in Mice

  2014cites this paper
• Neuroinflammation and immune regulation in ischemic stroke: identification of new pharmacological targets

  2014cites this paper
• Circulating adhesion molecules in obstructive sleep apnea and cardiovascular disease.

  2014cites this paper
• Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm

  2014cites this paper
• Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome

  2014cites this paper
• Found in translation: preclinical stroke research predicts human pathophysiology, clinical phenotypes, and therapeutic outcomes.

  2014cites this paper
• The Complement Cascade in Acute Brain Injury

  2014cites this paper
• Understanding the multifaceted role of inflammatory mediators in ischemic stroke.

  2014cites this paper
• Blocking of α 4 Integrin Does Not Protect From Acute Ischemic Stroke in Mice

  2014cites this paper
• Are we ready to translate T-cell transmigration in stroke?

  2014cites this paper
• Vascular Inflammation in Ischemic Stroke: Adhesion Receptors Controlling Leukocyte–Endothelial Interactions

  2014cites this paper
• Inhibition of Monocyte Adhesion to Brain-Derived Endothelial Cells by Dual Functional RNA Chimeras

  2014cites this paper
• Preclinical imaging of prostate cancer using radiolabeled antibodies

  2013cites this paper
• Pathogenesis of acute stroke and the role of inflammasomes.

  2013cites this paper
• Therapeutic Antibodies in Stroke

  2013cites this paper
• RNA-based blood genomics as an investigative tool and prospective biomarker for ischemic stroke

  2013cites this paper
• Caratterizzazione pre-clinica di una nuova strategia terapeutica per l'ischemia cerebrale identificata mediante drug repurposing di un antibiotico macrolide

  2013cites this paper
• A Concerted Appeal for International Cooperation in Preclinical Stroke Research

  2013cites this paper
• Progesterone Treatment for Experimental Stroke: An Individual Animal Meta-Analysis

  2013cites this paper
• Improving protein therapeutics through quantitative molecular engineering approaches and a cell-based oral delivery platform

  2013cites this paper
• Polymorphonuclear neutrophil infiltration into ischemic infarctions: myth or truth?

  2013cites this paper
• Targeted Drug Delivery to Endothelial Adhesion Molecules

  2013cites this paper
• Deletion of the ageing gene p66(Shc) reduces early stroke size following ischaemia/reperfusion brain injury.

  2013cites this paper
• Progesterone as a neuroprotectant in stroke

  2013cites this paper
• eview athogenesis of acute stroke and the role of inflammasomes avid

  2013influential citation
• The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury

  2012influential citation
• ADAMTS13 reduces VWF‐mediated acute inflammation following focal cerebral ischemia in mice

  2012cites this paper
• Effects of Gender on Gene Expression in the Blood of Ischemic Stroke Patients

  2012cites this paper
• The Splenic Response to Ischemic Stroke: Neuroinflammation, Immune Cell Migration, and Experimental Approaches to Defining Cellular Mechanisms

  2012cites this paper
• Systemic inflammation and its impact on the brain

  2012cites this paper
• The Translation Procedure of Low-Level Laser Therapy in Acute Ischemic Stroke: A Nonpharmaceutics Noninvasive Method

  2012cites this paper
• Postreanimationssyndrom

  2012cites this paper
• 53 – Pharmacologic Modification of Acute Cerebral Ischemia

  2011cites this paper
• 9 – Cerebral Ischemia and Inflammation

  2011cites this paper
• Clinical trials for cytoprotection in stroke

  2011cites this paper
• Immunological consequences of ischemic stroke: immunosuppression and autoimmunity.

  2011cites this paper
• Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte–endothelial interactions

  2011cites this paper
• Systemic Neutrophil Activation in a Mouse Model of Ischemic Stroke and Reperfusion

  2011cites this paper
• Pathophysiology, treatment, and animal and cellular models of human ischemic stroke

  2011cites this paper
• Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans

  2011influential citation
• Stroke and the immune system: from pathophysiology to new therapeutic strategies.

  2011cites this paper
• The immunology of stroke: from mechanisms to translation

  2011cites this paper
• The scavenger receptor CD36 contributes to the neurotoxicity of bone marrow-derived monocytes through peroxynitrite production.

  2011cites this paper
• Role of Cytotoxic Protease Granzyme‐b in Neuronal Degeneration During Human Stroke

  2011cites this paper
• The Potential of Tetrandrine as a Protective Agent for Ischemic Stroke

  2011cites this paper
• Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles?

  2011cites this paper
• Blocking TLR2 in vivo Protects against Accumulation of Inflammatory Cells and Neuronal Injury in Experimental Stroke

  2011cites this paper
• Intercellular adhesion molecule‐1 (ICAM‐1) in ulcerative colitis: presence, visualization, and significance

  2010cites this paper
• Mast Cells as Early Responders in the Regulation of Acute Blood–Brain Barrier Changes after Cerebral Ischemia and Hemorrhage

  2010cites this paper